BH3-only proteins and their effects on cancer

Advances in Experimental Medicine and Biology

Volumn 687, Issue , 2010, Pages 49-63

  Vo, Thanh Trang ^b   Letai, Anthony ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 RELATED PROTEIN A1; BH3 PROTEIN; BIM PROTEIN; BORTEZOMIB; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLUOROURACIL; GEFITINIB; GLUCOCORTICOID; HISTONE DEACETYLASE INHIBITOR; IMATINIB; PACLITAXEL; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN BNIP3; PROTEIN MCL 1; PROTEIN NOXA; PUMA PROTEIN; TUMOR NECROSIS FACTOR;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL STRESS; DOWN REGULATION; ENZYME ACTIVATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION REGULATION; GENE INSERTION; GENE TRANSLOCATION; HOMOZYGOSITY; HRK GENE; HYDROPHOBICITY; IMMUNOHISTOCHEMISTRY; MANTLE CELL LYMPHOMA; MITOCHONDRIAL MEMBRANE; NONHUMAN; OLIGOMERIZATION; ONCOGENE; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; ANIMAL; GENETICS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HUMANS; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 77958128601     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6706-0_3     Document Type: Article

References (124)

1. Enari M, Sakahira H, Yokoyama H et al. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 1998; 391(6662):43-50. (Pubitemid 28079208)
2. Khosravi-Far R, Esposti MD. Death receptor signals to mitochondria. Cancer Biol Ther 2004; 3(11):1051-1057. (Pubitemid 41350983)
3. Du C, Fang M, Li Y et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102(1):33-42.
4. Liu X, Kim CN, Yang J et al. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996; 86(1):147-157. (Pubitemid 26256586)
5. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15(22):2922-2933. (Pubitemid 33078942)
6. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 2000; 275(40):31199-31203.
7. Rodriguez J, Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev 1999; 13(24):3179-3184. (Pubitemid 30030439)
8. Zou H, Li Y, Liu X et al. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274(17):11549-11556.
9. Garcia-Saez AJ, Mingarro I, Perez-Paya E et al. Membrane-insertion fragments of Bcl-xL, Bax and Bid. Biochemistry 2004; 43(34):10930-10943. (Pubitemid 39433683)
10. Schlesinger PH, Saito M. The Bax pore in liposomes, Biophysics. Cell Death Differ 2006; 13(8):1403-1408. (Pubitemid 44057476)
11. Wei MC, Zong WX, Cheng EH et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 2001; 292(5517):727-730. (Pubitemid 32385543)
12. Wei MC, Lindsten T, Mootha VK et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 2000; 14(16):2060-2071. (Pubitemid 30637355)
13. Petros AM, Olejniczak ET, Fesik SW. Structural biology of the BCL-2 family of proteins. Biochim Biophys Acta 2004; 1644(2-3):83-94. (Pubitemid 38281265)
14. Hsu YT, Youle RJ. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 1998; 273(17):10777-10783. (Pubitemid 28227695)
15. Petros AM, Nettesheim DG, Wang Y et al. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis and biophysical studies. Protein Sci 2000; 9(12):2528-2534. (Pubitemid 32105735)
16. Cheng EH, Levine B, Boise LH et al. Bax-independent inhibition of apoptosis by BCL-XL. Nature 1996; 379(6565):554-556.
17. Certo M, Del Gaizo Moore V, Nishino M et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006; 9(5):351-365. (Pubitemid 43668734)
18. O'Connor L, Strasser A, O'Reilly LA et al. Bim: A novel member of the BCL-2 family that promotes apoptosis. EMBO J 1998; 17(2):384-395. (Pubitemid 28045479)
19. Wang K, Yin XM, Chao DT et al. BID: A novel BH3 domain-only death agonist. Genes Dev 1996; 10(22):2859-2869. (Pubitemid 26394246)
20. Yang E, Zha J, Jockel J et al. Bad, a heterodimeric partner for BCL-XL and BCL-2, displaces Bax and promotes cell death. Cell 1995; 80(2):285-291.
21. Boyd JM, Gallo GJ, Elangovan B et al. Bik, a novel death-inducing protein shares a distinct sequence motif with BCL-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 1995; 11(9):1921-1928.
22. Oda E, Ohki R, Murasawa H et al. Noxa, a BH3-only member of the BCL-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288(5468):1053-1058. (Pubitemid 30324238)
23. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7(3):683-694. (Pubitemid 32706359)
24. Inohara N, Ding L, Chen S et al. Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins BCL-2 and Bcl-X(L). EMBO J 1997; 16(7):1686-1694. (Pubitemid 27151963)
25. Puthalakath H, Villunger A, O'Reilly LA et al. Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 2001; 293(5536):1829-1832. (Pubitemid 32845780)
26. Zhong Q, Gao W, Du F et al. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005; 121(7):1085-1095. (Pubitemid 40884398)
27. Guo B, Godzik A, Reed JC. Bcl-G, a novel pro-apoptotic member of the BCL-2 family. J Biol Chem 2001; 276(4):2780-2785.
28. Yasuda M, Theodorakis P, Subramanian T et al. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J Biol Chem 1998; 273(20):12415-12421. (Pubitemid 28240613)
29. Oberstein A, Jeffrey PD, Shi Y. Crystal structure of the BCL-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 2007; 282(17):13123-13132. (Pubitemid 47100641)
30. Liu Z, Lu H, Jiang Z et al. Apolipoprotein l6, a novel proapoptotic BCL-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol Cancer Res 2005; 3(1):21-31. (Pubitemid 40189593)
31. Broustas CG, Gokhale PC, Rahman A et al. BRCC2, a novel BH3-like domain-containing protein, induces apoptosis in a caspase-dependent manner. J Biol Chem 2004; 279(25):26780-26788. (Pubitemid 38798836)
32. Mund T, Gewies A, Schoenfeld N et al. Spike, a novel BH3-only protein, regulates apoptosis at the endoplasmic reticulum. FASEB J 2003; 17(6):696-698.
33. Tan KO, Tan KM, Chan SL et al. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its BCL-2 homology domains. J Biol Chem 2001; 276(4):2802-2807.
34. Letai A, Bassik MC, Walensky LD et al. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002; 2(3):183-192. (Pubitemid 41043974)
35. Zong WX, Lindsten T, Ross AJ et al. BH3-only proteins that bind pro-survival BCL-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001; 15(12):1481-1486. (Pubitemid 32552527)
36. Kuwana T, Mackey MR, Perkins G et al. Bid, Bax and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002; 111(3):331-342. (Pubitemid 35341388)
37. Lovell JF, Billen LP, Bindner S et al. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 2008; 135(6):1074-1084.
38. Gavathiotis E, Suzuki M, Davis ML et al. BAX activation is initiated at a novel interaction site. Nature 2008; 455(7216):1076-1081.
39. Willis SN, Fletcher JI, Kaufmann T et al. Apoptosis initiated when BH3 ligands engage multiple BCL-2 homologs, not Bax or Bak. Science 2007; 315(5813):856-859.
40. Chipuk JE, Kuwana T, Bouchier-Hayes L et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004; 303(5660):1010-1014. (Pubitemid 38209704)
41. Kim H, Rafiuddin-Shah M, Tu HC et al. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 2006; 8(12):1348-1358. (Pubitemid 44835109)
42. Pagliari LJ, Kuwana T, Bonzon C et al. The multidomain proapoptotic molecules Bax and Bak are directly activated by heat. Proc Natl Acad Sci USA 2005; 102(50):17975-17980. (Pubitemid 41798487)
43. Cheng EH, Wei MC, Weiler S et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001; 8(3):705-711. (Pubitemid 32946946)
44. Chen L, Willis SN, Wei A et al. Differential targeting of prosurvival BCL-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17(3):393-403. (Pubitemid 40193310)
45. O'Reilly LA, Cullen L, Visvader J et al. The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal and germ cells. Am J Pathol 2000; 157(2):449-461. (Pubitemid 30626908)
46. Marani M, Tenev T, Hancock D et al. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol Cell Biol 2002; 22(11):3577-3589. (Pubitemid 34527138)
47. Adachi M, Zhao X, Imai K. Nomenclature of dynein light chain-linked BH3-only protein Bim isoforms. Cell Death Differ 2005; 12(2):192-193. (Pubitemid 40220650)
48. Puthalakath H, Huang DC, O'Reilly LA et al. The proapoptotic activity of the BCL-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 1999; 3(3):287-296. (Pubitemid 29290669)
49. Dijkers PF, Medema RH, Lammers JW et al. Expression of the pro-apoptotic BCL-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 2000; 10(19):1201-1204.
50. Reginato MJ, Mills KR, Paulus JK et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 2003; 5(8):733-740. (Pubitemid 36986781)
51. Lei K, Davis RJ. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 2003; 100(5):2432-2437. (Pubitemid 36297516)
52. Akiyama T, Bouillet P, Miyazaki T et al. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only BCL-2 family member Bim. EMBO J 2003; 22(24):6653-6664. (Pubitemid 38009611)
53. Barry M, Heibein JA, Pinkoski MJ et al. Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol Cell Biol 2000; 20(11):3781-3794. (Pubitemid 30314478)
54. Sutton VR, Davis JE, Cancilla M et al. Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J Exp Med 2000; 192(10):1403-1414.
55. Droga-Mazovec G, Bojic L, Petelin A et al. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic BCL-2 homologues. J Biol Chem 2008; 283(27):19140-19150.
56. Zha J, Weiler S, Oh KJ et al. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 2000; 290(5497):1761-1765. (Pubitemid 32004806)
57. Sax JK, Fei P, Murphy ME et al. BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 2002; 4(11):842-849. (Pubitemid 35331358)
58. Kamer I, Sarig R, Zaltsman Y et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 2005; 122(4):593-603. (Pubitemid 41191157)
59. Ranger AM, Zha J, Harada H et al. Bad-deficient mice develop diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 2003; 100(16):9324-9329. (Pubitemid 37033927)
60. Datta SR, Dudek H, Tao X et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91(2):231-241. (Pubitemid 27456390)
61. del Peso L, Gonzalez-Garcia M, Page C et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997; 278(5338):687-689. (Pubitemid 27464966)
62. Wang HG, Rapp UR, Reed JC. BCL-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996; 87(4):629-638. (Pubitemid 26386937)
63. Harada H, Becknell B, Wilm M et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol Cell 1999; 3(4):413-422. (Pubitemid 29292598)
64. Zha J, Harada H, Yang E et al. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996; 87(4):619-628. (Pubitemid 26386936)
65. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999; 284(5412):339-343. (Pubitemid 129523456)
66. Ayllon V, Martinez AC, Garcia A et al. Protein phosphatase 1alpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO J 2000; 19(10):2237-2246. (Pubitemid 30259005)
67. Chiang CW, Harris G, Ellig C et al. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin-3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood 2001; 97(5):1289-1297. (Pubitemid 32183751)
68. Mathai JP, Germain M, Marcellus RC et al. Induction and endoplasmic reticulum location of BIK/ NBK in response to apoptotic signaling by E1A and p53. Oncogene 2002; 21(16):2534-2544. (Pubitemid 34438106)
69. Verma S, Zhao LJ, Chinnadurai G. Phosphorylation of the pro-apoptotic protein BIK: Mapping of phosphorylation sites and effect on apoptosis. J Biol Chem 2001; 276(7):4671-4676.
70. Real PJ, Sanz C, Gutierrez O et al. Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells. FEBS Lett 2006; 580(25):5905-5909. (Pubitemid 44584291)
71. Han J, Flemington C, Houghton AB et al. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA 2001; 98(20):11318-11323. (Pubitemid 32928726)
72. Jeffers JR, Parganas E, Lee Y et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003; 4(4):321-328. (Pubitemid 37329796)
73. Villunger A, Michalak EM, Coultas L et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003; 302(5647):1036-1038. (Pubitemid 37386194)
74. Schmelzle T, Mailleux AA, Overholtzer M et al. Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis. Proc Natl Acad Sci USA 2007; 104(10):3787-3792. (Pubitemid 47181532)
75. Imaizumi K, Tsuda M, Imai Y et al. Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death. J Biol Chem 1997; 272(30):18842-18848. (Pubitemid 27318233)
76. Sanz C, Benito A, Inohara N et al. Specific and rapid induction of the proapoptotic protein Hrk after growth factor withdrawal in hematopoietic progenitor cells. Blood 2000; 95(9):2742-2747. (Pubitemid 30235877)
77. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100(1):57-70. (Pubitemid 30046295)
78. Bouillet P, Metcalf D, Huang DC et al. Proapoptotic BCL-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis and to preclude autoimmunity. Science 1999; 286(5445):1735-1738. (Pubitemid 129515880)
79. Egle A, Harris AW, Bouillet P et al. Bim is a suppressor of Myc-induced mouse B-cell leukemia. Proc Natl Acad Sci USA 2004; 101(16):6164-6169. (Pubitemid 38520545)
80. Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 2007; 109(1):271-280. (Pubitemid 46053067)
81. Zinkel SS, Ong CC, Ferguson DO et al. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev 2003; 17(2):229-239. (Pubitemid 36105895)
82. Krajewska M, Zapata JM, Meinhold-Heerlein I et al. Expression of BCL-2 family member Bid in normal and malignant tissues. Neoplasia 2002; 4(2):129-140. (Pubitemid 34218681)
83. Pompeia C, Hodge DR, Plass C et al. Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Res 2004; 64(10):3465-3473. (Pubitemid 38657919)
84. Sturm I, Stephan C, Gillissen B et al. Loss of the tissue-specific proapoptotic BH3-only protein Nbk/ Bik is a unifying feature of renal cell carcinoma. Cell Death Differ 2006; 13(4):619-627.
85. Hemann MT, Zilfou JT, Zhao Z et al. Suppression of tumorigenesis by the p53 target PUMA. Proc Natl Acad Sci USA 2004; 101(25):9333-9338. (Pubitemid 38812876)
86. Hoque MO, Begum S, Sommer M et al. PUMA in head and neck cancer. Cancer Lett 2003; 199(1):75-81. (Pubitemid 37098295)
87. Karst AM, Dai DL, Martinka M et al. PUMA expression is significantly reduced in human cutaneous melanomas. Oncogene 2005; 24(6):1111-1116. (Pubitemid 40313889)
88. Chin L, Merlino G, DePinho RA. Malignant melanoma: Modern black plague and genetic black box. Genes Dev 1998; 12(22):3467-3481. (Pubitemid 28553239)
89. Lee SH, Soung YH, Lee JW et al. Mutational analysis of Noxa gene in human cancers. APMIS 2003; 111(6):599-604. (Pubitemid 37130030)
90. Schmutte C, Tombline G, Rhiem K et al. Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH). Cancer Res 1999; 59(18):4564-4569. (Pubitemid 29428959)
91. Wick W, Petersen I, Schmutzler RK et al. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene 1996; 12(5):973-978. (Pubitemid 26104439)
92. Obata T, Toyota M, Satoh A et al. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. Clin Cancer Res 2003; 9(17):6410-6418. (Pubitemid 38031827)
93. Nieborowska-Skorska M, Hoser G, Kossev P et al. Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood 2002; 99(12):4531-4539. (Pubitemid 34627224)
94. Packham G, White EL, Eischen CM et al. Selective regulation of BCL-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev 1998; 12(16):2475-2487. (Pubitemid 28406951)
95. Zhou P, Levy NB, Xie H et al. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood 2001; 97(12):3902-3909.
96. Sinicrope FA, Rego RL, Okumura K et al. Prognostic impact of bim, puma and noxa expression in human colon carcinomas. Clin Cancer Res 2008; 14(18):5810-5818.
97. Sinicrope FA, Rego RL, Foster NR et al. Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers. Clin Cancer Res 2008; 14(13):4128-4133.
98. Lee JH, Soung YH, Lee JW et al. Inactivating mutation of the pro-apoptotic gene BID in gastric cancer. J Pathol 2004; 202(4):439-445. (Pubitemid 38456162)
99. Zantl N, Weirich G, Zall H et al. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: Evidence for contribution to apoptosis resistance. Oncogene 2007; 26(49):7038-7048. (Pubitemid 350014613)
100. Kohler B, Anguissola S, Concannon CG et al. Bid participates in genotoxic drug-induced apoptosis of HeLa cells and is essential for death receptor ligands' apoptotic and synergistic effects. PLoS ONE 2008; 3(7):e2844.
101. Fennell DA, Chacko A, Mutti L. BCL-2 family regulation by the 20S proteasome inhibitor bortezomib. Oncogene 2008; 27(9):1189-1197. (Pubitemid 351294694)
102. Shelton SN, Shawgo ME, Robertson JD. Cleavage of bid by executioner caspases mediates feed forward amplification of mitochondrial outer membrane permeabilization during genotoxic stress-induced apoptosis in jurkat cells. J Biol Chem 2009.
103. Song G, Chen GG, Chau DK et al. Bid exhibits S phase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in hepatocellular carcinoma cells. Apoptosis 2008; 13(5):693-701.
104. Cragg MS, Kuroda J, Puthalakath H et al. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. PLoS Med 2007; 4(10):1681-1689; discussion 1690.
105. Gilmore AP, Valentijn AJ, Wang P et al. Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. J Biol Chem 2002; 277(31):27643-27650. (Pubitemid 34966707)
106. Abrams MT, Robertson NM, Yoon K et al. Inhibition of glucocorticoid- induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA. J Biol Chem 2004; 279(53):55809-55817. (Pubitemid 40066588)
107. Erlacher M, Michalak EM, Kelly PN et al. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 2005; 106(13):4131-4138. (Pubitemid 41775918)
108. Zhang L, Insel PA. The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J Biol Chem 2004; 279(20):20858-20865. (Pubitemid 38656482)
109. Gillespie S, Borrow J, Zhang XD et al. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells. Apoptosis 2006; 11(12):2251-2265. (Pubitemid 44885400)
110. Zhang Y, Adachi M, Kawamura R et al. Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosis. Cell Death Differ 2006; 13(1):129-140.
111. Kuroda J, Puthalakath H, Cragg MS et al. Bim and Bad mediate imatinib-induced killing of Bcr/ Abl+leukemic cells and resistance due to their loss is overcome by a BH3 mimetic. Proc Natl Acad Sci USA 2006; 103(40):14907-14912. (Pubitemid 44527827)
112. Pradhan S, Kim HK, Thrash CJ et al. A critical role for the proapoptotic protein bid in ultraviolet- induced immune suppression and cutaneous apoptosis. J Immunol 2008; 181(5):3077-3088.
113. VanBrocklin MW, Verhaegen M, Soengas MS et al. Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma. Cancer Res 2009; 69(5):1985-1994.
114. Tan TT, Degenhardt K, Nelson DA et al. Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 2005; 7(3):227-238. (Pubitemid 40568682)
115. Li R, Moudgil T, Ross HJ et al. Apoptosis of nonsmall-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell Death Differ 2005; 12(3):292-303. (Pubitemid 40360952)
116. Janssen K, Pohlmann S, Janicke RU et al. Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood 2007; 110(10):3662-3672. (Pubitemid 350159635)
117. Kuribara R, Honda H, Matsui H et al. Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors. Mol Cell Biol 2004; 24(14):6172-6183. (Pubitemid 38891120)
118. Oltersdorf T, Elmore SW, Shoemaker AR et al. An inhibitor of BCL-2 family proteins induces regression of solid tumours. Nature 2005; 435(7042):677-681. (Pubitemid 40825512)
119. Del Gaizo Moore V, Brown JR, Certo M et al. Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. J Clin Invest 2007; 117(1):112-121. (Pubitemid 46048458)
120. Labi V, Grespi F, Baumgartner F et al. Targeting the BCL-2-regulated apoptosis pathway by BH3 mimetics: A breakthrough in anticancer therapy? Cell Death Differ 2008; 15(6):977-987. (Pubitemid 351712602)
121. Kang MH, Kang YH, Szymanska B et al. Activity of vincristine, L-ASP and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. Blood 2007; 110(6):2057-2066. (Pubitemid 47443923)
122. Deng J, Carlson N, Takeyama K et al. BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 2007; 12(2):171-185. (Pubitemid 47199122)
123. van Delft MF, Wei AH, Mason KD et al. The BH3 mimetic ABT-737 targets selective BCL-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 2006; 10(5):389-399. (Pubitemid 44711953)
124. Konopleva M, Contractor R, Tsao T et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 2006; 10(5):375-388. (Pubitemid 44693472)